Using neurons created from iPS cells derived from people with ALS, researchers develop a new drug which appears to halt the impact of the genetic mutations in some forms of ALS and dementia.
Researchers create neurons from the skin cells of ALS patients in order to "treat" a gene defect in a dish.
Researchers have identified a new toxic entity associated with genetically inherited forms of frontotemporal dementia and motor neuron disease.
Researchers discover how a genetic code variation in the C9orf72 gene alters the shape of DNA, making cells more vulnerable to stress and apoptosis.
Researchers discover how a specific genetic mutation leads to neuronal damage associated with ALS and frontotemporal dementia.
Researchers believe mouse could provide a new platform for testing treatments for several neurodegenerative diseases.
According to new research, the C9orf72 mutation causes long strands of RNA to block specific pathways which usually move proteins into a cell's nucleus.
Findings provide new hope for treating ALS and FTD, researchers report.
A new study points to a potential new target to treat neurodegenerative diseases.
Immune cells appear to play a direct role in the development of ALS, a new study reports.
Researchers report the most common genetic mutation associated with ALS plays an important role in not only the nervous system, but also the blood and immune systems.
Researchers report they have identified two regions of a mouse brain where a gene implicated in ALS is expressed.
